This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF's funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

This Year's Speakers

• Dirk Beher, Aceneuron
• Elizabeth Bradshaw, Brigham and Women's Hospital
• Carol Colton, Duke University Medical Center
• Mari DeMarco, University of British Columbia
• Pontus Forsell, AlzeCure Foundation
• Michael Gold, PPD
• Atticus Hainsworth, St. George, University of London
• Ihab Hajjar, Emory University
• Mansuo Hayashi, Eli Lilly and Company
• Lawrence Honig, Columbia University
• Edward Huey, Columbia University
• Berkley Lynch, Rodin Therapeutics
• Alexandros Makriyannis, Northeastern University
• Yukari Perrella, Yuma Therapeutics
• Jerri Rook, Vanderbilt Center of Neuroscience Drug Discovery
• Sharon Rosenzweig-Lipson, AgeneBio
• Stephen Salton, Icahn School of Medicine at Mount Sinai
• Grace Stutzmann, Rosalind Franklin University of Science and Medicine
• Paul Thompson, University of Massachusetts
• Raymond Scott Turner, Georgetown University
• Shijun Zhang, Virginia Commonwealth University
• Danna Zimmer, University of Maryland School of Medicine